Although EpCAM and CSV are considered as common targets for epithelial and mesenchymal CTCs, respectively, antibodies against tissue specific antigen, such as human epidermal growth factor receptor 2 (HER2) for BCa and prostate specific membrane antigen (PSMA) for PCa, should be also included in this study. The gene discussed is EPCAM; the disease is posterior cortical atrophy.